Hypoglossal nerve stimulation has been a major breakthrough in the treatment of obstructive sleep apnea for patients unable to tolerate positive airway pressure therapy. Inspire Medical Systems had the first technology approved by the US Food and Drug Administration in 2014, and I was the first surgeon in the Western United States to offer this…
Respiratory sensing lead risks with the Inspire IV system
The Upper Airway Stimulation system from Inspire Medical Systems has been an important and effective treatment option for many patients with obstructive sleep apnea. Like any procedure or technology, there are potential important risks to consider. In the United States, the Food and Drug Administration (FDA) maintains the publicly-available Manufacturer and User Facility Device Experience… Read more »